These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25485183)

  • 1. Modulation of Transcription mediated by the Vitamin D Receptor and the Peroxisome Proliferator-Activated Receptor δ in the presence of GW0742 analogs.
    Teske K; Nandhikonda P; Bogart JW; Feleke B; Sidhu P; Yuan N; Preston J; Goy R; Arnold LA
    J Biomol Res Ther; 2014; 3(1):. PubMed ID: 25485183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on the GW0742 Scaffold.
    Teske KA; Rai G; Nandhikonda P; Sidhu PS; Feleke B; Simeonov A; Yasgar A; Jadhav A; Maloney DJ; Arnold LA
    ACS Comb Sci; 2017 Oct; 19(10):646-656. PubMed ID: 28825467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.
    Nandhikonda P; Yasgar A; Baranowski AM; Sidhu PS; McCallum MM; Pawlak AJ; Teske K; Feleke B; Yuan NY; Kevin C; Bikle DD; Ayers SD; Webb P; Rai G; Simeonov A; Jadhav A; Maloney D; Arnold LA
    Biochemistry; 2013 Jun; 52(24):4193-203. PubMed ID: 23713684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel VDR antagonists based on the GW0742 scaffold.
    Teske KA; Bogart JW; Arnold LA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):351-354. PubMed ID: 29287957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
    Chang WT; Cheng JT; Chen ZC
    Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
    Okazaki S; Shioi R; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
    Bioorg Med Chem; 2016 Nov; 24(21):5455-5461. PubMed ID: 27622746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    Bisgaier CL; Oniciu DC; Srivastava RAK
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):3-10. PubMed ID: 29621036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triterpenoids from Hibiscus sabdariffa L. with PPARδ/γ Dual Agonist Action: In Vivo, In Vitro and In Silico Studies.
    Giacoman-Martínez A; Alarcón-Aguilar FJ; Zamilpa A; Hidalgo-Figueroa S; Navarrete-Vázquez G; García-Macedo R; Román-Ramos R; Almanza-Pérez JC
    Planta Med; 2019 Mar; 85(5):412-423. PubMed ID: 30650453
    [No Abstract]   [Full Text] [Related]  

  • 11. Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-γ coactivator-1α-dependent vitamin D receptor pathway.
    Feigerlova E; Demarquet L; Melhem H; Ghemrawi R; Battaglia-Hsu SF; Ewu E; Alberto JM; Helle D; Weryha G; Guéant JL
    FASEB J; 2016 Oct; 30(10):3598-3612. PubMed ID: 27435264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
    Shende VR; Singh AB; Liu J
    Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the PPAR-β/δ agonist GW0742 during resuscitated porcine septic shock.
    Wepler M; Hafner S; Scheuerle A; Reize M; Gröger M; Wagner F; Simon F; Matallo J; Gottschalch F; Seifritz A; Stahl B; Matejovic M; Kapoor A; Möller P; Calzia E; Georgieff M; Wachter U; Vogt JA; Thiemermann C; Radermacher P; McCook O
    Intensive Care Med Exp; 2013 Dec; 1(1):28. PubMed ID: 26266797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets?
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):383-6. PubMed ID: 20214982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.
    Mikami D; Kimura H; Kamiyama K; Torii K; Kasuno K; Takahashi N; Yoshida H; Iwano M
    Hypertens Res; 2014 May; 37(5):422-31. PubMed ID: 24352213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation.
    Fredenrich A; Grimaldi PA
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):377-81. PubMed ID: 15192438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.
    Shi Y; Hon M; Evans RM
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor δ inhibits Porphyromonas gingivalis lipopolysaccharide-induced activation of matrix metalloproteinase-2 by downregulating NADPH oxidase 4 in human gingival fibroblasts.
    Yoo T; Ham SA; Hwang JS; Lee WJ; Paek KS; Oh JW; Kim JH; Do JT; Han CW; Kim JH; Seo HG
    Mol Oral Microbiol; 2016 Oct; 31(5):398-409. PubMed ID: 26403493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.